Rittenmeyer's stock holdings have seen significant growth while he has been at Tenet Healthcare. In 2019, his holdings were valued at about $15 million and steadily increased over the years, peaking at $78.17 million in September 2024. This rise reflects...

Stock Sold

$69.64M

IQV

$11.27M

69,582 shares

THC

$58.37M

918,603 shares

What if they kept their stock?

If Ronald Rittenmeyer didn't sell their stock, today they would have:
Extra IQV69,582 shares worth $13.73M and THC918,603 shares worth $120.21M.
This is 92.35% and $64.31M more than what they got when they sold the stock.

Recent Insider Trades

IQV

995 shares

IQV

May 11, 2022

Received

THC

$17.22M

THC at $90.56/share

Mar 2, 2022

Sale

THC

$5.39M

THC at $90.12/share

Mar 2, 2022

Sale

THC

$451.51K

THC at $77.86/share

Dec 16, 2021

Sale

THC

$462.84K

THC at $76.00/share

Dec 10, 2021

Sale

THC

$5.01M

THC at $76.03/share

Dec 7, 2021

Sale

THC

$859.52K

THC at $76.01/share

Dec 7, 2021

Sale

Charitable Transactions

IQV

290 shares

IQV

Recent Charitable Transactions

No charitable transactions found for this CEO.

Ronald Rittenmeyer

Ex-CEO of Tenet Healthcare

RR

View Compensation History

2021 Total Compensation

$18.67M

Salary

$1.50M

Bonus

$6.75M

Stock

$10.00M

Other

$416.15K